Navigation Links
Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations
Date:10/1/2007

LOS ANGELES, Oct. 1 /PRNewswire-FirstCall/ -- Sunnylife Global, Inc. (Pink Sheets: SNYL) has retained The Blaine Group for investor relations and financial public relations services.

At a time when there's a major need to develop superior quality healthcare management in China and build assisted-living housing for the nation's aging population, Sunnylife Global is positioned to do so, with approvals from China's central government.

"We are thrilled to have been retained to represent a company with much needed solutions such as those that Sunnylife Global provides," explained Devon Blaine, president and CEO of The Blaine Group. "Their timing to market is perfect and their President and Chairman, Richard Lo, truly understands that his multi-national corporation has social and environmental responsibilities as well as profit initiatives. He is fully prepared to accept and meet the challenge to create a sustainable economy globally," she concluded.

About Sunnylife Global

Sunnylife Global, Inc., (Pink Sheets: SNYL) has 21 signed agreements with the PRC for the upgrade of their level 2 hospitals to international standards and $20 million of financing has been received for the upgrade of the first two hospitals. This alone will create $2 million in annual revenue. The enrollment process of the 50,000 government employees per hospital, as members of Sunnylife's Healthcare Management System (HMO), has begun. The company has plans for building and operating assisted living care centers. 46,000 people have pre-applied and been approved by the government. The first 3,000 units are scheduled for completion mid-2008. $19 million in financing is in place for this and annual yield should be $3.8 million beginning July 2008.

About The Blaine Group

The Blaine Group, "A Total Communications Agency" founded in 1975, offers public relations, marketing strategies and advertising campaigns as comprehensive communications campaigns or as stand-alone entities. It also handles investor relations and financial public relations activities for its publicly-traded clients.

The Blaine Group is located at 8665 Wilshire Blvd., Suite #301, Beverly Hills, CA 90211. The telephone number is 310/360-1499, the FAX number is 310/360-1498, and the URL is http://www.blainegroupinc.com.

The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. For additional information, please consult the Company's most recent public filings and 10-K. The Company assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise.

FOR FURTHER INFORMATION, CONTACT: Devon Blaine

The Blaine Group

310/360-1499

310/360-1498 (FAX)

blaine@blainegroupinc.com


'/>"/>
SOURCE Sunnylife Global, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Skin Cancer Research To Go Global
2. Dementia - a global problem
3. Obesity a global problem
4. Suggestions to reduce global heart disease burden
5. Drop in global deaths from measles
6. First global SARS meet opens
7. SARS-Free Taiwan to Mark End Phase of Global Fight
8. Prevent Global Warming by Becoming A Vegetarian
9. India To March Ahead in The Global HealthCare Competition
10. Global Outbreak Of Bird Flu Warning By Chinese Scientist
11. TWO India Doctors Listed in TIME for Contribution to Global Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology: